Peptide record

TPDB93302

[Tyr10] Secretin-27 Blood-Brain Barrier modified_plain modified
27 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB93302
[Tyr10] Secretin-27
Blood-Brain Barrier
Delivery and barrier-penetrating peptides
B3Pred BBPpredict Peptipedia
modified_plain
Yes
A 27-aa modified blood-brain barrier peptide sequence curated from B3Pred, BBPpredict, and Peptipedia, with an available 3D structural model.
C-terminal: Chemical modification N-terminal: C-terminal modification
Sequence
HSDGTFTSEYSRLRDSARLQRLLQGLV
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
27 reviewed residue count
Chemical modification Activity
Linear Activity
C-terminal modification Activity
His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val Activity
[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O Activity
Evidence Records 4 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
0.000899 mL/(g x min)

Assay & Model

Unidirectional influx rate constant

Source & Reference

NA
B3Pdb

Other

Gila monster
Intravenous
non saturable
Direct iodination
Evidence 2 Activity

Activity

Blood-Brain Barrier
0.0121 ml/g

Assay & Model

Initial distribution volume

Source & Reference

NA
B3Pdb

Other

Gila monster
Intravenous
non saturable
Direct iodination
Evidence 3 Activity

Activity

Blood-Brain Barrier
2%

Assay & Model

Capillary depletion
% capillary

Source & Reference

NA
B3Pdb

Other

Gila monster
Direct iodination
Evidence 4 Activity

Activity

Blood-Brain Barrier
98%

Assay & Model

Capillary depletion
% parenchyma

Source & Reference

NA
B3Pdb

Other

Gila monster
Direct iodination
Additional Detail Fields 1 fields
Intravenous